// COMPANY
Newpath Partners
SECTOR VENTURE CAPITALMENTIONS 1LAST SEEN AUGUST 19, 2026
Discussed in
// RECENT MENTIONS
// SIGNALS
1 SIGNAL
01
funding·PitchBook News·AUGUST 19, 2026
“Leal Therapeutics raised $30 million in a Series A extension with investment from Eli Lilly, OrbiMed and Newpath Partners.”
Source→AI-extracted from podcast / newsletter / paper summaries. May contain errors.